Kymera Therapeutics, Inc(NASDAQ:KYMR) 
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase...
Website: http://www.kymeratx.com
Founded: 2016
Full Time Employees: 64
CEO: Nello Mainolfi
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 22.82
H 22.99
L 21.40
C 22.07
V 1,195,191
10EMA 22.07
20EMA 22.07
60EMA 22.07
120EMA 22.07
250EMA 22.07